Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: Risk without reward

Por Abbas, Ume L., Mellors, John W.
Publicado em 2002

Potential Impact of Antiretroviral Chemoprophylaxis on HIV-1 Transmission in Resource-Limited Settings

Por Abbas, Ume L., Anderson, Roy M., Mellors, John W.
Publicado em 2007

Factors Influencing the Emergence and Spread of HIV Drug Resistance Arising from Rollout of Antiretroviral Pre-Exposure Prophylaxis (PrEP)

Por Abbas, Ume L., Hood, Gregory, Wetzel, Arthur W., Mellors, John W.
Publicado em 2011

Antiretroviral Therapy and Pre-exposure Prophylaxis: Combined Impact on HIV Transmission and Drug Resistance in South Africa

Por Abbas, Ume L., Glaubius, Robert, Mubayi, Anuj, Hood, Gregory, Mellors, John W.
Publicado em 2013

Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa

Por Glaubius, Robert L., Hood, Greg, Penrose, Kerri J., Parikh, Urvi M., Mellors, John W., Bendavid, Eran, Abbas, Ume L.
Publicado no Clin Infect Dis (2016)

Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention

Por Glaubius, Robert L., Parikh, Urvi M., Hood, Greg, Penrose, Kerri J., Bendavid, Eran, Mellors, John W., Abbas, Ume L.
Publicado no Open Forum Infect Dis (2016)